Central Jersey Blood Center, Inc. FDA Inspection Record

FEI 2270821 · Inspections, Form 483s, warning letters and import refusals

Central Jersey Blood Center, Inc. is an FDA-inspected facility (FEI 2270821) located in Shrewsbury, NJ, US. RegDataLab tracks 5 FDA inspections at this facility.

What FDA found at this site

Latest inspection
Mar 2, 2017: No Action Indicated (NAI)
Inspections on record
5 (1 VAI, 4 NAI)
Last OAI inspection
None on record
Warning letters
None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Recalls as the recalling firm
20, latest Jul 5, 2007

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Mar 2, 2017No Action Indicated (NAI)No citations listed
Nov 4, 2014No Action Indicated (NAI)No citations listed
Mar 12, 2013No Action Indicated (NAI)No citations listed
Jun 16, 2011No Action Indicated (NAI)No citations listed
Jul 10, 2009Voluntary Action Indicated (VAI)Suitable size, construction, etc. (21 CFR 606.40)
Provide space for examination (21 CFR 606.40(a)(1))
Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b))

Recalls

Showing the 10 most recent of 20 recalls. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Jul 5, 2007Class IIB-0798-08Platelets Pheresis Leukocytes Reduced Irradiated
Blood product, which was possibly contaminated with Propionibacterium Acnes, was distributed.
Apr 10, 2007Class IIB-0744-08Platelets Pheresis Leukocytes Reduced
Blood product, which was possibly contaminated with Propionibacterium acnes, was distributed.
Mar 9, 2007Class IIB-0797-08Platelets Pheresis Leukocytes Reduced
Blood products, which were possibly contaminated with Propionibacterium Acnes, were distributed.
Feb 21, 2007Class IIB-1503-07Fresh Frozen Plasma (Apheresis)
Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
Dec 4, 2006Class IIB-1450-07Red Blood Cells Leukocytes Reduced Irradiated
Blood products, which were collected from a donor who had traveled to a malarial endemic area, were distributed.
Nov 29, 2006Class IIB-1481-07Platelets Pheresis Leukocytes Reduced Irradiated
Blood products, which were collected from a donor who had traveled to a malarial endemic area, were distributed.
Apr 28, 2006Class IIB-0328-08Red Blood Cells Leukocytes Reduced and 1 more product
Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed.
Aug 8, 2005Class IIB-1605-07Recovered Plasma
Blood product, which was collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), was…
Mar 31, 2004Class IIB-1449-5Red Blood Cells (Apheresis) and 1 more product
Blood products, collected on an instrument that had not been validated for use, were distributed.
Feb 5, 2004Class IIIB-1990-5Red Blood Cells
Blood products, collected from a donor whose temperature was not documented, were distributed.

FDA record score

0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 16, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

16 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJul 10, 200910 years or older, so it adds no points0
Class II recall B-0798-08, this FEI as the recalling firmJul 5, 200710 years or older, so it adds no points0
Class II recall B-0744-08, this FEI as the recalling firmApr 10, 200710 years or older, so it adds no points0
Class II recall B-0797-08, this FEI as the recalling firmMar 9, 200710 years or older, so it adds no points0
Class II recall B-1503-07, this FEI as the recalling firmFeb 21, 200710 years or older, so it adds no points0
Class II recall B-1450-07, this FEI as the recalling firmDec 4, 200610 years or older, so it adds no points0
Class II recall B-1481-07, this FEI as the recalling firmNov 29, 200610 years or older, so it adds no points0
Class II recall B-0328-08, this FEI as the recalling firmApr 28, 200610 years or older, so it adds no points0
Class II recall B-1605-07, this FEI as the recalling firmAug 8, 200510 years or older, so it adds no points0
Class II recall B-1449-5, this FEI as the recalling firmMar 31, 200410 years or older, so it adds no points0
Class II recall B-1991-5, this FEI as the recalling firmFeb 5, 200410 years or older, so it adds no points0
Class II recall B-2436-5, this FEI as the recalling firmMar 28, 200310 years or older, so it adds no points0
Class II recall B-1992-5, this FEI as the recalling firmMar 17, 200310 years or older, so it adds no points0
Class I recall B-1180-3, this FEI as the recalling firmJan 23, 200310 years or older, so it adds no points0
Class II recall B-0931-3, this FEI as the recalling firmJul 29, 200210 years or older, so it adds no points0
Class II recall B-0997-3, this FEI as the recalling firmJun 25, 200110 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 16, 2026Newest record Nov 5, 2026Current
Inspection citationsNov 16, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 16, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 16, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 13, 2026Newest record Nov 12, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Central Jersey Blood Center, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Central Jersey Blood Center, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Central Jersey Blood Center, Inc.
Location
Shrewsbury, NJ (US)
Source
inspections

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.